Sisomicin sulfate
(Synonyms: 硫酸西索米星) 目录号 : GC32263
Sisomicin sulfate是一种由伊诺单孢菌（Micromonospora inyoensis）产生的天然氨基糖苷类抗生素，对革兰氏阳性菌具有很强的活性。
Cas No.:53179-09-2
Sample solution is provided at 25 µL, 10mM.
_1-3.$$$39978408@51.jpg');)
_1-9.$$$38538795@65.jpg');)
_1-9.$$$39112701@51.jpg');)
_1-7.$$$37316672@70.jpg');)
_366-372.$$$36198801@70.jpg');)
.$$$38565142@65.jpg');)
_1867-1883.$$$33248023@67.jpg');)
_eads6055.$$$39977546@45.jpg');)
_eadm9805.$$$40080571@45.jpg');)
_eadj3020.$$$39666821@45.jpg');)
_1-20.$$$39757301@28.jpg');)
_1-24.$$$38898113@28.jpg');)
_273-287.$$$36806353@46.jpg');)
_1-16.$$$37156877@44.jpg');)
_1-19.$$$37460805@44.jpg');)
_1291-1307.$$$34518654@46.jpg');)
Sisomicin sulfate is a naturally occurring aminoglycoside antibiotic produced by Micromonospora inyoensis and has strong activity against Gram-positive bacteria[1].
In vitro, Compared to the wild-type Mycobacterium smegmatis, the PdtaS gene deletion (ΔpdtaS) mutant shows increased sensitivity to Sisomicin sulfate (2.3μg/ml; 3, 6, 9 and 24h)[2]. Sisomicin sulfate (20μg/mL; 30min) does not interfere with the function of polymorphonuclear neutrophils (PMN)[3].
In vivo, Hypertonic Sisomicin sulfate (20mg/ml) can be used for intracochlear perfusion to construct an inner ear injury model in mice[4]. Sisomicin sulfate (20mg/kg; i.p.) caused a decrease in neuromuscular twitch tension in rabbits[5].
References:
[1] Noone P. Sisomicin sulfate, netilmicin and dibekacin. A review of their antibacterial activity and therapeutic use. Drugs. 1984 Jun;27(6):548-78.
[2] Dadura K, Płocińska R, Rumijowska-Galewicz A, et al. PdtaS Deficiency Affects Resistance of Mycobacteria to Ribosome Targeting Antibiotics. Front Microbiol. 2017 Nov 3;8:2145.
[3] Le Moli S, Seminara R, D'Amelio R, et al. In vitro and in vivo effect of Sisomicin sulfate and gentamycin on polymorphonuclear chemotaxis and phagocytosis. Int J Immunopharmacol. 1983;5(1):49-54.
[4] Maraslioglu-Sperber A, Blanc F, Heller S, et al. Hyperosmotic Sisomicin sulfate infusion: a mouse model for hearing loss. Sci Rep. 2024 Jul 10;14(1):15903.
[5] Matsukawa S, Suh JH, Hashimoto Y, et al. Neuromuscular blocking actions of the aminoglycoside antibiotics Sisomicin sulfate and micronomicin in the rabbit. Tohoku J Exp Med. 1997 Apr;181(4):471-3.
Sisomicin sulfate是一种由伊诺单孢菌（Micromonospora inyoensis）产生的天然氨基糖苷类抗生素，对革兰氏阳性菌具有很强的活性[1]。
在体外实验中，与野生型分枝杆菌（Mycobacterium smegmatis）相比，PdtaS基因敲除（ΔpdtaS）突变株对Sisomicin sulfate（2.3µg/ml; 3, 6, 9和24h）的敏感性增加[2]。Sisomicin sulfate (20μg/mL; 30min) 不会干扰多形核中性粒细胞(PMN) 功能[3]。
在体内实验中，高渗Sisomicin sulfate（20mg/ml; 耳内灌注）可用于构建小鼠内耳损伤模型[4]。Sisomicin sulfate（20mg/kg; i.p.）导致兔子神经肌肉抽搐张力降低[5]。
| Cell experiment [1]: | |
Cell lines | Mycobacterium smegmatis |
Preparation Method | The survival of M. smegmatis ΔpdtaS mutant cells grown in liquid medium with the addition of selected antibiotics was studied using standard colony-forming unit (CFU) methodology. Actively growing cells from the logarithmic stage of growth were diluted in 7H9 medium supplemented with OADC and Tween-80 to an OD600 of 0.1. Sisomicin sulfate at a final concentration of 2.3μg/ml was used. The kinetics of growth was measured by recording OD600 at 3, 6, 9 and 24h after the addition of antibiotics. At the 9 and 24h time points, 10-fold serial dilutions of cells were spread on 7H10 agar containing OADC. Plates were incubated at 37°C for 3-5 days, colonies were counted, and data were plotted using Excel. A Student's t-test was performed to determine the statistical significance between the test and control values. |
Reaction Conditions | 2.3μg/ml; 3, 6, 9 and 24h |
Applications | Compared to the wild-type Mycobacterium smegmatis, the PdtaS gene deletion (ΔpdtaS) mutant shows increased sensitivity to Sisomicin sulfate. |
| Animal experiment [2]: | |
Animal models | Rabbits |
Preparation Method | Twenty rabbits weighing 2.2-4.4kg were subjected to tracheotomy after anesthesia induction. Mechanical ventilation was controlled to maintain arterial carbon dioxide pressure (PaCO₂) between 35-45mmHg. Blood pressure and arterial blood gas analysis were monitored through a catheterized carotid artery. The external jugular vein was cannulated for fluid (5%D/W, at a rate of 10ml/kg/hr) and drug administration. The left gastrocnemius tendon was cut and secured to a U-type force-displacement transducer. A heating pad was used to maintain body temperature above 36°C, and the muscle was housed in a clear enclosure warmed by a heat lamp. A thermometer in contact with the muscle surface measured muscle temperature. The left tibial nerve was cut after dissection from the sciatic nerve and covered with mineral oil. The cut tibial nerve was directly stimulated using a stimulator and 27 gauge thin-walled steel-needle electrodes. Maximal square-wave pulses (0.1ms duration) were delivered at a rate of 0.1Hz. The resultant isometric force of muscle twitch tension and arterial blood pressure were continuously recorded on a Nihon Kohden polygraph. When a stable twitch was obtained, an initial dose of Sisomicin sulfate (20mg/kg, n=7) was administered intravenously, and the initial dose and maximum percentage of twitch inhibition were determined. Additional Sisomicin sulfate (10mg/kg) was given to study the response to twitch inhibition exceeding 90%. |
Dosage form | 20mg/kg; i.p. |
Applications | Sisomicin sulfate caused a decrease in neuromuscular twitch tension in rabbits. |
References: | |
| Cas No. | 53179-09-2 | SDF | |
| 别名 | 硫酸西索米星 | ||
| Canonical SMILES | N[C@H]1[C@](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@@](O)(C)[C@H](NC)[C@H]3O)[C@H]2O)([H])OC(CN)=CC1.[2.5H2SO4] | ||
| 分子式 | C19H37N5O7 . 5/2 H2SO4 | 分子量 | 692.72 |
| 溶解度 | Water : 20 mg/mL (28.87 mM) | 储存条件 | Store at -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 1.4436 mL | 7.2179 mL | 14.4358 mL |
| 5 mM | 288.7 μL | 1.4436 mL | 2.8872 mL |
| 10 mM | 144.4 μL | 721.8 μL | 1.4436 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet